Combined effects of the angiogenic genes polymorphisms on prostate cancer susceptibility and aggressiveness

Molecular Biology Reports

Volumn 36, Issue 1, 2009, Pages 37-45

  Sfar, Sana ^a   Saad, Hamadi ^b   Mosbah, Faouzi ^c   Chouchane, Lotfi ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^c EPS Sahloul ^*  (Tunisia)

Author keywords

Angiogenic pathway; Cancer prognosis; Combined analysis; Gene gene interactions; Genetic susceptibility; Prostate cancer

Indexed keywords

GELATINASE B; THROMBOSPONDIN 1; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; DNA POLYMORPHISM; GENE DOSAGE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC RISK; HETEROZYGOSITY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PENETRANCE; PROGNOSIS; PROSTATE CANCER;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSTATIC NEOPLASMS; THROMBOSPONDIN 1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 56649123321     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-007-9149-4     Document Type: Article

References (56)

1. ACS (2004) Cancer facts and figures. Atlanta: Amercian Cancer Socitey
2. P Lichtenstein NV Holm PK Verkasalo A Iliadou J Kaprio M Koskenvuo E Pukkala A Skytthe K Hemminki 2000 Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 2 78 85
3. N Weidner 1995 Intratumor microvessel density as a prognostic factor in cancer Am J Pathol 147 9 19
4. LM Ellis IJ Fidler 1996 Angiogenesis and metastasis Eur J Cancer 32 14 2451 2460
5. D Hanahan J Folkman 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 353 364
6. J Folkman 1995 Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 27 31
7. W Auerbach R Auerbach 1994 Angiogenesis inhibition: a review Pharmacol Ther 63 265 311
8. J Folkman M Klagsbrun 1987 Angiogenic factors Science 235 442 447
9. N Ferrara T Davis-Smyth 1997 The biology of vascular endothelial growth factor Endocr Rev 18 1 4 25
10. FA Ferrer LJ Miller R Lindquist P Kowalczyk VP Laudone PC Albertsen DL Kreutzer 1999 Expression of vascular endothelial growth factor receptors in human prostate cancer Urology 54 3 567 572
11. WG Stetler-Stevenson 1999 Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention J Clin Invest 103 1237 1244
12. WG Stetler-Stevenson S Aznavoorian LA Liotta 1993 Tumor cell interactions with the extracellular matrix during invasion and metastasis Annu Rev Cell Biol 9 541 573
13. G Murphy J Gavrilovic 1999 Proteolysis and cell migration: creating a path? Curr Opin Cell Biol 11 614 621
14. G Bergers R Brekken G McMahon 2000 Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nat Cell Biol 2 737 744
15. BC Sheu SM Hsu HN Ho HC Lien SC Huang RH Lin 2001 A novel role of metalloproteinase in cancer mediated immunosuppression Cancer Res 61 237 242
16. TH Vu JM Shipley G Bergers JE Berger JA Helms D Hanahan SD Shapiro RM Senior Z Werb 1998 MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes Cell 93 3 411 422
17. Q Huang HM Shen CN Ong 2004 Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB Biochem Pharmacol 68 361 371
18. RA Bok S Halabi DT Fei CR Rodriquez DF Hayes NJ Vogelzang P Kantoff MA Shuman EJ Small 2001 Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone refractory prostate cancer patients: a cancer and leukemia group B study Cancer Res 61 6 2533 2536
19. C Vallbo JE Damber 2005 Thrombospondins, metallo proteases and thrombospondin receptors messenger RNA and protein expression in different tumour sublines of the Dunning prostate cancer model Acta Oncol 44 293 298
20. DJ Good PJ Polverini F Rastinejad MM Le Beau RS Lemons WA Frazier NP Bouck 1990 A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin Proc Natl Acad Sci USA 87 17 6624 6628
21. T Vogel NH Guo HC Krutzsch DA Blake J Hartman S Mendelovitz A Panet DD Roberts 1993 Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin J Cell Biochem 53 1 74 84
22. SS Tolsma OV Volpert DJ Good WA Frazier PJ Polverini N Bouck 1993 Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity J Cell Biol 122 2 497 511
23. B Jiménez OV Volpert SE Crawford M Febbraio RL Silverstein N Bouck 2000 Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 Nat Med 6 1 41 48
24. N Guo HC Krutzsch JK Inman DD Roberts 1997 Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells Cancer Res 57 9 1735 1742
25. J Lawler M Detmar 2004 Tumor progression: the effects of thrombospondin-1 and -2 Int J Biochem Cell Biol 36 1038 1045
26. S Sfar E Hassen H Saad F Mosbah L Chouchane 2006 Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome Cytokine 35 12 21 28
27. S Sfar H Saad F Mosbah S Gabbouj L Chouchane 2007 TSP1 and MMP9 genetic variants in sporadic prostate cancer Cancer Genet Cytogenet 172 1 38 44
28. SA Miller DD Dykes HF Polesky 1988 A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1215
29. SL McCarron S Edwards PR Evans R Gibbs DP Dearnaley A Dowe C Southgate DF Easton RA Eeles WM Howell 2002 Influence of cytokine gene polymorphisms on the development of prostate cancer Cancer Res 62 12 3369 3372
30. DJ Schaid 2004 The complex genetic epidemiology of prostate cancer Hum Mol Genet 13 103 121
31. J Folkman 1992 The role of angiogenesis in tumor growth Semin Cancer Biol 3 65 71
32. N Weidner 1995 Intratumor microvessel density as a prognostic factor in cancer Am J Pathol 147 9 19
33. CJ Watson NJ Webb MJ Bottomley PE Brenchley 2000 Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production Cytokine 12 8 1232 1235
34. M Shahbazi AA Fryer V Pravica IJ Brogan HM Ramsay IV Hutchinson PN Harden 2002 Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection J Am Soc Nephrol 13 1 260 264
35. MI Koukourakis D Papazoglou A Giatromanolaki G Bougioukas E Maltezos E Sivridis 2004 VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer Lung Cancer 46 3 293 298
36. D Lambrechts E Storkebaum M Morimoto J Del-Favero F Desmet SL Marklund S Wyns V Thijs J Andersson I van Marion A Al-Chalabi S Bornes R Musson V Hansen L Beckman R Adolfsson HS Pall H Prats S Vermeire P Rutgeerts S Katayama T Awata N Leigh L Lang-Lazdunski M Dewerchin C Shaw L Moons R Vlietinck KE Morrison W Robberecht C Van Broeckhoven D Collen PM Andersen P Carmeliet 2003 VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death Nat Genet 34 383 394
37. T Awata K Inoue S Kurihara T Ohkubo M Watanabe K Inukai I Inoue S Katayama 2002 A common polymorphism in the 50-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes Diabetes 51 5 1635 1639
38. T Awata S Kurihara N Takata T Neda H Iizuka T Ohkubo M Osaki M Watanabe Y Nakashima K Inukai I Inoue I Kawasaki K Mori S Yoneya S Katayama 2005 Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes Biochem Biophys Res Commun 333 3 679 685
39. B Zhang S Ye SM Herrmann P Eriksson M de Maat A Evans D Arveiler G Luc F Cambien A Hamsten H Watkins AM Henney 1999 Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis Circulation 99 1788 1794
40. N Weidner PR Carroll J Flax W Blumenfeld J Folkman 1993 Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma Am J Pathol 143 2 401 409
41. MR Freeman FX Schneck ML Gagnon C Corless S Soker K Niknejad GE Peoples M Klagsbrun 1995 Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis Cancer Res 55 4140
42. JL Owen V Iragavarapu-Charyulu Z Gunja-Smith LM Herbert JF Grosso DM Lopez 2003 Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor J Immunol 171 8 4340 4351
43. AM Miltenburg S Lacraz HG Welgus JM Dayer 1995 Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts J Immunol 154 2655
44. DI Gabrilovich HL Chen KR Girgis HT Cunningham GM Meny S Nadaf D Kavanaugh DP Carbone 1996 Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Nat Med 2 1096
45. H Wang JA Keiser 1998 Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1 Circ Res 83 832
46. HK Rooprai GJ Rucklidge C Panou GJ Pilkington 2000 The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells Brit J Cancer 82 52
47. S Dias K Hattori Z Zhu B Heissig M Choy W Lane Y Wu A Chadburn E Hyjek M Gill DJ Hicklin L Witte MA Moore S Rafii 2000 Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration J Clin Invest 106 511
48. EJ Topol J McCarthy S Gabriel DJ Moliterno WJ Rogers LK Newby M Freedman J Metivier R Cannata CJ O'Donnell K Kottke-Marchant G Murugesan EF Plow O Stenina GQ Daley 2001 Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction Circulation 104 2641 2644
49. BL Hannah TM Misenheimer MM Pranghofer DF Mosher 2004 A polymorphism in thrombospondin-1 associated with familial premature coronary artery disease alters Ca2p binding J Biol Chem 279 51915 51922
50. BL Hannah TM Misenheimer DS Annis DF Mosher 2003 A polymorphism in thrombospondin-1 associated with familial premature coronary heart disease causes a local change in conformation of the Ca2p-binding repeats J Biol Chem 278 8929 8934
51. J Lawler LH Derick JE Connolly JH Chen FC Chao 1985 The structure of human platelet thrombospondin J Biol Chem 260 3762 3772
52. NV Narizhneva VJ Byers-Ward MJ Quinn FJ Zidar EF Plow EJ Topol TV Byzova 2004 Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction J Biol Chem 279 21651 21657
53. R Mazzucchelli R Montironi A Santinelli G Lucarini A Pugnaloni G Biagini 2000 Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients Prostate 45 72 79
54. C Vallbo JE Damber 2005 Thrombospondins, metallo proteases and thrombospondin receptors messenger RNA and protein expression in different tumour sublines of the Dunning prostate cancer model Acta Oncol 44 293 298
55. JC Rodriguez-Manzaneque TF Lane MA Ortega RO Hynes J Lawler ML Iruela-Arispe 2001 Thrombospondin-1 supresses tumor growth by a novel mechanism that includes blockade of matrix matalloproteinase-9 activation Proc Natl Acad Sci USA 98 12485 12490
56. K Gupta P Gupta R Wild S Ramakrishnan RP Hebbel 1999 Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis Angiogenesis 3 147 158